{
    "id": 30505,
    "fullName": "BAX G179E",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BAX G179E lies within the transmembrane domain of the Bax protein (UniProt.org). G179E is associated with BCL2 inhibitor resistance (PMID: 24786774), but has not been biochemically characterized and therefore, its effect on Bax protein function is unknown (PubMed, Jul 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 15676,
                    "pubMedId": 24786774,
                    "title": "Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24786774"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 581,
        "geneSymbol": "BAX",
        "terms": [
            "BAX",
            "BCL2L4"
        ]
    },
    "variant": "G179E",
    "createDate": "07/12/2019",
    "updateDate": "07/12/2019",
    "referenceTranscriptCoordinates": {
        "id": 180888,
        "transcript": "NM_138761",
        "gDna": "chr19:g.48961593G>A",
        "cDna": "c.536G>A",
        "protein": "p.G179E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17583,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BAX G179E was identified as an acquired mutation in a mantle cell lymphoma (MCL) cell line with resistance to Venclexta (venetoclax) in culture and in xenograft models, and expression of BAX G179E was unable to restore sensitivity to Venclexta (venetoclax) in Venclexta (venetoclax)-resistant MCL cells in culture (PMID: 24786774).",
            "molecularProfile": {
                "id": 32688,
                "profileName": "BAX G179E"
            },
            "therapy": {
                "id": 1562,
                "therapyName": "Venetoclax",
                "synonyms": null
            },
            "indication": {
                "id": 50746,
                "name": "mantle cell lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15676,
                    "pubMedId": 24786774,
                    "title": "Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24786774"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32688,
            "profileName": "BAX G179E",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 180889,
            "transcript": "NM_138764",
            "gDna": "chr19:g.48961632_48961633delGCinsAG",
            "cDna": "c.536_537delGCinsAG",
            "protein": "p.G179E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 180888,
            "transcript": "NM_138761",
            "gDna": "chr19:g.48961593G>A",
            "cDna": "c.536G>A",
            "protein": "p.G179E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}